Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

3(75%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_1

25%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Detailed Status

Recruiting3

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (25.0%)

Phase 31 (25.0%)

N/A2 (50.0%)

Trials by Status

recruiting375%

completed125%

Recent Activity

3 active trials

Showing 4 of 4

recruitingnot_applicable

REMASTer: REcurrent Brain Metastases After SRS Trial

NCT05124912

recruitingnot_applicable

Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss

NCT07235488

recruitingphase_1

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

NCT05443425

completedphase_3

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

NCT00978549

Clinical Trials (4)

Showing 4 of 4 trials

NCT05124912Not Applicable

REMASTer: REcurrent Brain Metastases After SRS Trial

Recruiting

NCT07235488Not Applicable

Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss

Recruiting

NCT05443425Phase 1

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

Recruiting

NCT00978549Phase 3

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4